Items where authors include "Russell, R.G.G."
Article
Steijvers, E. orcid.org/0009-0004-1035-3886, Shi, Y., Lu, H. et al. (16 more authors) (2025) Rapid assessment of the osteogenic capacity of hydroxyapatite/aragonite using a murine tibial periosteal ossification model. Bioactive Materials, 45. pp. 257-273. ISSN 2452-199X
Sedghizadeh, P.P. orcid.org/0000-0003-4190-0497, Cherian, P. orcid.org/0000-0002-1070-6483, Roshandel, S. et al. (11 more authors) (2023) Real-time impedance-based monitoring of the growth and inhibition of osteomyelitis biofilm pathogen Staphylococcus aureus treated with novel bisphosphonate-fluoroquinolone antimicrobial conjugates. International Journal of Molecular Sciences, 24 (3). 1985. ISSN 1661-6596
Sedghizadeh, P.P., Sun, S., Jones, A.C. et al. (8 more authors) (2021) Bisphosphonates in dentistry: historical perspectives, adverse effects, and novel applications. Bone, 147. 115933. p. 115933. ISSN 8756-3282
Sun, S., Tao, J., Sedghizadeh, P.P. et al. (13 more authors) (2021) Bisphosphonates for delivering drugs to bone. British Journal of Pharmacology, 178 (9). pp. 2008-2025. ISSN 0007-1188
Vijen, S., Hawes, C., Runions, J. et al. (5 more authors) (2020) Differences in intracellular localisation of ANKH mutants that relate to mechanisms of calcium pyrophosphate deposition disease and craniometaphyseal dysplasia. Scientific Reports, 10. 7408. ISSN 2045-2322
Cronin, O. orcid.org/0000-0002-1365-9942, Forsyth, L., Goodman, K. et al. (39 more authors) (2019) Zoledronate in the prevention of Paget's (ZiPP) : protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone. BMJ Open, 9 (9). e030689.
Cremers, S. orcid.org/0000-0002-6800-5532, Drake, M.T. orcid.org/0000-0002-3662-7345, Ebetino, F.H. et al. (2 more authors) (2019) Pharmacology of bisphosphonates. British Journal of Clinical Pharmacology, 85 (6). pp. 1052-1062. ISSN 0306-5251
Ralston, S.H., Corral-Gudino, L., Cooper, C. et al. (14 more authors) (2019) Diagnosis and management of Paget's disease of bone in adults: a clinical guideline. Journal of Bone and Mineral Research, 34 (4). pp. 579-604. ISSN 0884-0431
Lawson, M.A. orcid.org/0000-0002-5446-923X, Ebetino, F.H., Mazur, A. et al. (14 more authors) (2017) The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate). Journal of Bone and Mineral Research, 32 (9). pp. 1860-1869. ISSN 0884-0431
Sedghizadeh, P.P., Sun, S., Junka, A.F. et al. (13 more authors) (2017) Design, synthesis, and antimicrobial evaluation of a novel bone-targeting bisphosphonate-ciprofloxacin conjugate for the treatment of osteomyelitis biofilms. Journal of Medicinal Chemistry, 60 (6). pp. 2326-2343. ISSN 0022-2623
Misra, J., Mohanty, S.T., Madan, S. et al. (4 more authors) (2015) Zoledronate Attenuates Accumulation of DNA Damage in Mesenchymal Stem Cells and Protects Their Function. Stem Cells. ISSN 1066-5099
Pazianas, M., Cooper, C., Wang, Y. et al. (2 more authors) (2011) Atrial fibrillation and the use of oral bisphosphonates. Therapeutics and Clinical Risk Management, 7. pp. 131-144. ISSN 1176-6336